Menu
Search
Home > Courses > Quadrivalent HPV vaccine in HIV-positive and HIV-negative men who have sex with men

Quadrivalent HPV vaccine in HIV-positive and HIV-negative men who have sex with men

Quadrivalent HPV vaccine in HIV-positive and HIV-negative men who have sex with men
Sorry, this learning module is not available for mobile devices.
This video is available at the Physicians Research Network website.

Original Release Date: 5/18/2010
Review Date: 5/18/2010
Presenter
  • Stephen E. Goldstone, MD, FACS
    Assistant Clinical Professor of Surgery
    Mount Sinai School of Medicine
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Understand the efficacy of quadrivalent HPV vaccine in preventing anal intraepithelial neoplasia in men who have sex with men.
  2. Understand the efficacy of quadrivalent HPV vaccine at preventing anal HPV infection in men who have sex with men.
  3. Discuss the safety profile of quadrivalent HPV vaccine in HIV-positive men.
Presenter Bio
Stephen Goldstone, MD, FACS
Stephen E. Goldstone is an Assistant Clinical Professor of Surgery at The Icahn School of Medicine at Mount Sinai and has a surgical practice in New York City. Dr. Goldstone has spoken at conferences around the world and has done extensive research on human papillomavirus (HPV). His work has been published in many prestigious medical journals, and is currently involved in testing both prevention and treatment procedures for HPV. He is a past-president of the International Anal Neoplasia Society and a member of the AIDS Malignancy Consortium.
PRN Learning Modules